ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 1 filers reported holding ORCHARD THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $477,000 | -42.7% | 361,736 | 0.0% | 0.01% | -50.0% |
Q3 2021 | $832,000 | +103.4% | 361,736 | +542.5% | 0.01% | +55.6% |
Q1 2021 | $409,000 | -87.1% | 56,297 | -92.3% | 0.01% | -89.3% |
Q4 2020 | $3,177,000 | +363.1% | 735,455 | +340.6% | 0.08% | +281.8% |
Q3 2020 | $686,000 | -60.9% | 166,909 | -42.9% | 0.02% | -68.1% |
Q2 2020 | $1,754,000 | -60.6% | 292,250 | -50.6% | 0.07% | -78.3% |
Q1 2020 | $4,452,000 | +187.2% | 591,250 | +424.4% | 0.32% | +404.8% |
Q4 2019 | $1,550,000 | – | 112,756 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CHI Advisors LLC | 5,307,751 | $3,101,000 | 1.18% |
TANG CAPITAL MANAGEMENT LLC | 2,000,000 | $1,168,000 | 0.18% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $4,060,000 | 0.08% |
Artal Group S.A. | 1,803,858 | $1,054,000 | 0.06% |
GSA CAPITAL PARTNERS LLP | 616,402 | $360,000 | 0.05% |
RA Capital Management | 3,040,885 | $1,776,000 | 0.05% |
Forefront Analytics, LLC | 92,641 | $58,000 | 0.03% |
Temasek Holdings (Private) Ltd | 4,319,049 | $2,523,188 | 0.01% |
FEDERATED HERMES, INC. | 8,309,859 | $4,853,000 | 0.01% |
Cormorant Asset Management, LP | 256,649 | $150,000 | 0.01% |